Physician profile
Eric Warren
NPI 1427518257
$1,164.72
in general payments reported to CMS, 2019-2025
16 companies · $220 in 2025
The $220 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $209 · 2023: $551 · 2024: $184 · 2025: $220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $955.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $955.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $249.59 | 2022-2023 | Ubrelvy, Qulipta |
| Novo Nordisk INC | $176.95 | 2022-2025 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals Lp | $112.59 | 2022-2025 | Farxiga, Airsupra |
| Merck Sharp & Dohme LLC | $101.24 | 2023-2024 | Gardasil 9, Vaxelis, Vaxneuvance |
| Bayer Healthcare Pharmaceuticals INC. | $93.72 | 2023-2025 | |
| Lilly USA, LLC | $85.77 | 2022-2025 | Mounjaro, Zepbound |
| Kowa Pharmaceuticals America, INC. | $56.94 | 2024-2025 | Zoryve |
| Biohaven Pharmaceutical Holding Company Ltd. | $51.46 | 2022 | |
| Boston Scientific Corporation | $47.70 | 2023-2024 | Watchman Access System |
| Pfizer INC. | $40.28 | 2023 | |
| Mylan Specialty L.P. | $39.01 | 2023 | Yupelri |
| Mannkind Corporation | $30.54 | 2023 | Afrezza |
| Sanofi-Aventis U.S. LLC | $23.82 | 2022 | |
| Philips North America LLC | $18.95 | 2024 | (Ck7) Extended Holter |
| Amgen INC. | $18.86 | 2024 | Evenity, Prolia |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $17.30 | 2023 | Doc Band |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Warren listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.